CytoDyn Inc. (CYDY)
OTCMKTS · Delayed Price · Currency is USD
0.3300
+0.0100 (3.13%)
Dec 10, 2025, 4:00 PM EST
CytoDyn Market Cap
CytoDyn has a market cap or net worth of $413.9 million as of December 11, 2025. Its market cap has increased by 194.50% in one year.
Market Cap
413.90M
Enterprise Value
431.87M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.33
Market Cap Chart
Since November 17, 2005, CytoDyn's market cap has increased from 5.54M to 413.90M, an increase of 7,374.44%. That is a compound annual growth rate of 23.97%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 10, 2025 | 413.90M | 207.43% |
| Dec 31, 2024 | 134.63M | -29.42% |
| Dec 29, 2023 | 190.74M | 2.63% |
| Dec 30, 2022 | 185.85M | -72.64% |
| Dec 31, 2021 | 679.28M | -78.86% |
| Dec 31, 2020 | 3.21B | 695.20% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 815.80M |
| Elite Pharmaceuticals | 561.88M |
| Glass House Brands | 513.14M |
| American Oncology Network | 365.47M |
| Northwest Biotherapeutics | 363.73M |
| Silence Therapeutics | 328.75M |
| Nika Pharmaceuticals | 259.91M |
| HST Global | 131.71M |